Introducing PEPAXTO: The first anticancer peptide-drug conjugate for multiple myeloma patients who have received ≥4 prior lines and are triple-class refractory
Presented by: Kathleen Colson, RN Clinical Research Nurse, Multiple Myeloma International Myeloma Foundation
Wednesday, September 22, 2021 06:00 PM EDT
The Capital Grille
900 Boylston Street
Boston, MA 02115
To register for this program, please contact your Oncopeptides representative: Chris Woodford 207.754.6141 or chris.woodford@oncopeptides.com
Please RSVP at least 3 days in advance of the program
See attached flyer.
Comments